sch 16134 has been researched along with flurazepam in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (73.08) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 1 (3.85) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mahowald, MW; Walsh, JK | 1 |
| Battista, D; Hilbert, JM | 1 |
| Dement, WC | 1 |
| Roehrs, TA; Roth, T | 1 |
| Kauert, G; Klausnitzer, W; Schaffler, K; Wauschkuhn, CH | 1 |
| Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Gevins, AS; Ragsdale, SD; Stone, RK | 1 |
| Barnett, A; Ongini, E | 1 |
| Ellinwood, EH; Gupta, SK | 1 |
| Kawasaki, H; Nuki, C; Ohno, H; Takasaki, K; Urabe, M; Yamamoto, R | 1 |
| Barnett, A; Hilbert, JM; Iorio, L; Moritzen, V; Symchowicz, S; Zampaglione, N | 1 |
| Kales, A; Kales, JD; Soldatos, CR | 1 |
| Bixler, EO; Kales, A; Soldatos, CR; Vela-Bueno, A | 1 |
| Fumagalli, R; Iuliano, E; Ongini, E; Racagni, G | 1 |
| Carskadon, M; Dement, W; Seidel, W | 1 |
| Bixler, EO; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Sieghart, W | 1 |
| Mariotti, M; Ongini, E | 1 |
| Gural, RP; Hilbert, JM; Symchowicz, S; Zampaglione, N | 1 |
| Chung, M; Gural, R; Hilbert, JM; Radwanski, E; Symchowicz, S; Zampaglione, N | 1 |
| Chung, M; Gural, RP; Hilbert, JM; Radwanski, E; Symchowicz, S; Zampaglione, N | 1 |
| Chung, M; Gural, R; Hilbert, JM; Maier, G; Symchowicz, S; Zampaglione, N | 1 |
| Bixler, EO; Jacoby, J; Kales, A; Kales, JD; Soldatos, CR; Vela-Bueno, A | 1 |
| Aoshima, T; Fukasawa, T; Kanno, M; Kato, K; Otani, K; Suzuki, A; Yasui-Furukori, N | 1 |
| Ohno, Y; Yamaguchi, K; Zhou, J | 1 |
5 review(s) available for sch 16134 and flurazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cricetinae; Flurazepam; Humans; Hypnotics and Sedatives; Kinetics; Mice; Molecular Structure; Rats; Saimiri; Sleep Initiation and Maintenance Disorders; Tissue Distribution | 1991 |
A review of the safety profiles of benzodiazepine hypnotics.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; Hypnotics and Sedatives; Middle Aged; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam | 1991 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Behavioral side effects of benzodiazepine hypnotics.
Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Disorders; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Substance-Related Disorders; Triazolam | 1985 |
3 trial(s) available for sch 16134 and flurazepam
| Article | Year |
|---|---|
Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Anxiety Agents; Benzodiazepines; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flurazepam; Half-Life; Humans; Hypnotics and Sedatives; Male; Middle Aged; Placebos; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders | 1991 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug.
Topics: Administration, Oral; Adult; Area Under Curve; Benzodiazepines; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Flurazepam; Half-Life; Humans; Hypnotics and Sedatives; Itraconazole; Male; Psychomotor Performance; Sleep | 2003 |
19 other study(ies) available for sch 16134 and flurazepam
| Article | Year |
|---|---|
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam | 1991 |
Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Electrooculography; Flurazepam; Hemodynamics; Humans; Male; Psychomotor Performance; Reaction Time; Respiration; Substance Withdrawal Syndrome | 1989 |
Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. A neural-network pattern classification analysis.
Topics: Adult; Algorithms; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Electroencephalography; Evoked Potentials; Flurazepam; Humans; Male; Nerve Net; Nervous System; Signal Processing, Computer-Assisted; Sleep Stages; Triazolam | 1988 |
Hypnotic specificity of benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Cats; Diazepam; Electroencephalography; Flurazepam; Hypnotics and Sedatives; Receptors, GABA-A; Sleep | 1985 |
Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam.
Topics: Administration, Sublingual; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Biological Availability; Biotransformation; Chromatography, High Pressure Liquid; Flurazepam; Humans; Male | 1988 |
[Electroencephalographic study of Sch 161 (quazepam), a new benzodiazepine hypnotic, in rats and rabbits].
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Electric Stimulation; Electroencephalography; Flurazepam; Hypnotics and Sedatives; Photic Stimulation; Rabbits; Rats; Reticular Formation; Sound | 1987 |
Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Dose-Response Relationship, Drug; Electroshock; Flurazepam; Male; Metabolic Clearance Rate; Mice; Seizures | 1986 |
Quazepam: sleep laboratory studies of effectiveness and withdrawal.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 1985 |
Effects of quazepam and flurazepam on GABA-ergic transmission in mouse cerebellum: relationship between biochemical and behavioral activity.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cerebellum; Cyclic GMP; Flurazepam; gamma-Aminobutyric Acid; Isoniazid; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Cell Surface; Receptors, GABA-A | 1981 |
Daytime alertness, insomnia, and benzodiazepines.
Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Lorazepam; Male; Oxazepam; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Wakefulness | 1982 |
Early morning insomnia with rapidly eliminated benzodiazepines.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1983 |
Several new benzodiazepines selectively interact with a benzodiazepine receptor subtype.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Cerebellum; Flunitrazepam; Flurazepam; Hippocampus; Membranes; Rats; Receptors, Cell Surface; Receptors, GABA-A | 1983 |
Differential effects of benzodiazepines on EEG activity and hypnogenic mechanisms of the brain stem in cats.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Stem; Cats; Decerebrate State; Diazepam; Electroencephalography; Flurazepam; Pentobarbital; Sleep | 1983 |
Excretion of quazepam into human breast milk.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Female; Flurazepam; Humans; Milk, Human | 1984 |
Quazepam kinetics in the elderly.
Topics: Absorption; Administration, Oral; Aged; Aging; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chromatography, Gas; Female; Flurazepam; Half-Life; Humans; Kinetics; Male | 1984 |
Multiple-dose quazepam kinetics.
Topics: Absorption; Administration, Oral; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Flurazepam; Humans; Kinetics; Male | 1984 |
Effect of sleep on quazepam kinetics.
Topics: Absorption; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Flurazepam; Half-Life; Humans; Kinetics; Male; Random Allocation; Sleep; Time Factors | 1984 |
Quazepam and flurazepam: long-term use and extended withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Drug Evaluation; Flurazepam; Half-Life; Humans; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors | 1982 |
Quantitative analysis of quazepam and its metabolites in human blood, urine, and bile by liquid chromatography-tandem mass spectrometry.
Topics: Benzodiazepines; Benzodiazepinones; Bile; Chromatography, Liquid; Flurazepam; Forensic Toxicology; Humans; Hypnotics and Sedatives; Male; Middle Aged; Molecular Structure; Tandem Mass Spectrometry | 2014 |